Loading company…
Quanterix develops instruments and assays for measuring biomarkers and supporting disease research and diagnosis.
Founded in 2007 and based in Massachusetts, US, Quanterix develops biomarker analysis instruments and assay kits for life sciences research. Its Simoa platforms and kits support work in cardiology, infectious disease, inflammation, neurology and oncology. The company trades on NASDAQ as QTRX.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in